Filed pursuant to Rule 424(b)(3)
Registration No. 333-261112
PROSPECTUS SUPPLEMENT NO. 1
(to Prospectus dated November 29, 2021)
![LOGO](https://capedge.com/proxy/424B3/0001193125-21-364961/g276487g1222074904378.jpg)
29,042,827 Shares
Nikola Corporation
Common Stock
This prospectus supplement supplements the prospectus dated November 29, 2021 (the “Prospectus”), which forms a part of our registration statement on Form S-1 (No. 333-261112). This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our current report on Form 8-K, filed with the Securities and Exchange Commission on December 22, 2021 (the “Current Report”). Accordingly, we have attached the Current Report to this prospectus supplement.
The Prospectus and this prospectus supplement relates to the offer and sale of up to 29,042,827 shares of our common stock, $0.0001 par value per share (“Common Stock”), by the selling stockholders named in the Prospectus or their donees, pledgees, transferees or other successors in interest.
Our Common Stock is listed on the Nasdaq Global Select Market under the symbol “NKLA”. On December 21, 2021, the closing price of our Common Stock was $9.42.
This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.
See the section entitled “Risk Factors” beginning on page 11 of the Prospectus and in the documents incorporated by reference in the Prospectus to read about factors you should consider before buying our securities.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is December 22, 2021.